
Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine auto injector Symjepi in the …

The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of last summer, continuing to grab …
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow. This …

The release of Teva Pharmaceuticals generic for the anaphylaxis treatment, EpiPen (epinephrine), is now expected to be severely delayed after …
The growth of the auto injector industry has been driven largely in part by the need to improve patient compliance …
Tokyo, Japan – SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that …
SHL first introduced the Amberâ„¢ auto injector utilizing Pushclickâ„¢ technology at the PDA (Parental Drug Association) event in Basel, Switzerland …
SHL recognizes the importance of this topic and discusses it in more details in an article titled “Auto Injector Innovation” …
SHL’s recent article “Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers” was featured in …
SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, officially announced reaching a new milestone …
SHL Group, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, signed a second Letter of …
As demand for self-injection devices such as auto injectors and pen injectors continues to rise, drug delivery device suppliers must …
SHL will be presenting and exhibiting at the upcoming 10th Annual BIO Asia International Conference from January 29-30th in Tokyo, …